The current valuation score of Autolus Therapeutics PLC is 7.49, ranking 228 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.37, which is -18.61% below the recent high of -1.12 and -391.79% above the recent low of -6.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.